Abstract
AbstractCeramide, the central molecule of the sphingomyelin pathway, serves as a second messenger for cellular functions ranging from proliferation and differentiation to growth arrest and apoptosis. In this study we show that c2‐ceramide induces apoptosis in primary cortical neuron cultures and that this effect correlates with differential modulation of mitogen‐activated protein kinase (MAPK) cascades. Phosphorylation of extracellular signal‐regulated kinases (ERKs) and their upstream activators MAPK kinases (MEKs), as measured by immunoblotting is rapidly decreased by c2‐ceramide. However, the MEK inhibitor PD98059 alone does not induce apoptosis and in combination with c2‐ceramide it does not modify c2‐ceramide‐induced apoptosis. Treatment with c2‐ceramide increases p38 and c‐Jun N‐terminal kinase (JNK) phosphorylation before and during caspase‐3 activation. The p38 inhibitor SB203580 partially protects cortical neurons against c2‐ceramide‐induced apoptosis, implicating the p38 pathway in this process. The c2‐ceramide treatment also increases levels of c‐jun, c‐fos and p53 mRNA in primary cortical neuron cultures, but this is independent of p38 activation. Our study further elucidates the time‐courses of MAPK cascade modulation, and of c‐jun, c‐fos and p53 activation during c2‐ceramide‐induced neuronal apoptosis. It reveals that one of the activated kinases, p38, is necessary for this apoptosis.
Bibliography
Willaime, S., Vanhoutte, P., Caboche, J., LemaigreâDubreuil, Y., Mariani, J., & Brugg, B. (2001). Ceramideâinduced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation. European Journal of Neuroscience, 13(11), 2037â2046. Portico.
References
81
Referenced
97
10.1083/jcb.143.6.1691
10.1016/S0079-6336(76)80015-0
10.1016/S0022-2275(20)34198-5
10.1016/S0021-9258(19)74304-X
10.1038/sj.bjp.0703534
10.1074/jbc.272.35.22173
10.1046/j.1471-4159.1996.66020733.x
10.1074/jbc.272.5.3028
10.1038/sj.onc.1202276
10.1002/(sici)1097-4547(19980401)52:1<69::aid-jnr7>3.0.co;2-i
10.1016/0014-5793(95)00357-f
10.1002/j.1460-2075.1993.tb05680.x
10.1016/S0092-8674(00)00116-1
10.1016/S0960-9822(98)70019-3
10.1016/S0021-9258(18)42727-5
10.1016/S0021-9258(18)82288-8
10.1126/science.275.5300.661
10.1073/pnas.92.17.7686
10.1523/JNEUROSCI.18-05-01713.1998
10.1523/JNEUROSCI.17-20-07736.1997
10.1083/jcb.127.6.1717
10.1046/j.1471-4159.1997.69041612.x
10.1083/jcb.150.2.335
10.1097/00001756-199807130-00001
10.1016/s0959-4388(99)00010-0
10.1002/j.1460-2075.1996.tb00636.x
10.1038/sj.onc.1202603
10.1016/0896-6273(95)90331-3
10.1016/s0169-328x(00)00074-7
10.1016/s0014-2999(98)00857-7
10.1126/science.274.5294.1855
10.1016/s0014-5793(96)01460-3
10.1016/s0006-8993(97)01410-8
10.1016/s0006-8993(99)02009-0
10.1073/pnas.94.14.7531
10.1006/exnr.1999.7126
10.1016/s0014-5793(99)00034-4
10.1016/0006-8993(86)91222-9
10.1042/bj3301009
10.1523/JNEUROSCI.10-02-00558.1990
/ J. Neurosci. / Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin‐like growth factors I and II by Knusel B. (1990)10.1016/0092-8674(94)90147-3
10.1097/00004647-199703000-00001
10.1016/s0006-8993(99)01061-6
10.1074/jbc.271.22.13169
10.1038/372739a0
10.1083/jcb.142.3.625
10.1523/JNEUROSCI.18-01-00104.1998
10.1083/jcb.106.3.829
10.1002/1521-1878(200007)22:7<637::AID-BIES6>3.0.CO;2-E
10.1042/bj3350465
10.1002/(sici)1097-4547(19980315)51:6<712::aid-jnr5>3.3.co;2-q
10.1523/JNEUROSCI.16-04-01337.1996
10.1016/s0304-3940(00)01655-4
10.1523/JNEUROSCI.20-17-06442.2000
10.1126/science.8456305
10.1016/0012-1606(90)90180-Q
10.1074/jbc.270.23.13585
10.1073/pnas.91.16.7525
10.1016/S0092-8674(00)80091-4
10.1006/exnr.1994.1216
10.1006/bbrc.1997.7527
10.1523/JNEUROSCI.17-09-02929.1997
10.1074/jbc.272.13.8141
10.1016/0006-3002(63)90513-4
10.1111/j.1471-4159.1978.tb10804.x
10.1523/JNEUROSCI.19-15-06235.1999
10.1016/S0952-7915(96)80131-2
10.1093/emboj/16.16.4973
10.1023/A:1021008626887
10.1016/S0955-0674(96)80067-6
10.1006/excr.2000.4939
10.1523/JNEUROSCI.18-02-00751.1998
10.1074/jbc.270.39.22689
10.1128/MCB.18.4.2416
10.1074/jbc.273.12.7141
10.1016/S0021-9258(17)32128-2
10.1126/science.270.5240.1326
10.1016/S0960-9822(98)70020-X
10.1084/jem.191.6.1017
10.1016/S0092-8674(00)80183-X
10.1074/jbc.M001185200
Dates
Type | When |
---|---|
Created | 22 years, 5 months ago (March 6, 2003, 9:36 a.m.) |
Deposited | 1 year, 10 months ago (Oct. 3, 2023, 11:43 a.m.) |
Indexed | 1 month, 3 weeks ago (July 7, 2025, 1:25 a.m.) |
Issued | 24 years, 2 months ago (June 1, 2001) |
Published | 24 years, 2 months ago (June 1, 2001) |
Published Online | 23 years, 8 months ago (Dec. 20, 2001) |
Published Print | 24 years, 2 months ago (June 1, 2001) |
@article{Willaime_2001, title={Ceramide‐induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation}, volume={13}, ISSN={1460-9568}, url={http://dx.doi.org/10.1046/j.0953-816x.2001.01581.x}, DOI={10.1046/j.0953-816x.2001.01581.x}, number={11}, journal={European Journal of Neuroscience}, publisher={Wiley}, author={Willaime, Sandrine and Vanhoutte, Peter and Caboche, Jocelyne and Lemaigre‐Dubreuil, Yolande and Mariani, Jean and Brugg, Bernard}, year={2001}, month=jun, pages={2037–2046} }